Explained: How a cancer drug cuts risk of death in Covid-19 patients - The Indian Express

According to the study, the “cumulative mortality analysis showed that the reduction in deaths with sabizabulin started within the first week of treatment and the relative reduction in deaths reached 51.8% at day 29”.

A newly published phase-3 study for the drug sabizabulin, initially developed to fight cancer, has shown that it cuts risk of death by about one-fourth in patients hospitalized with moderate to sever… [+4001 chars]

full article...